Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Orenstein

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
The Journal of the American Osteopathic Association|October 30, 2014
Emerging infections: the cauldron of medicine, mobility, and mediaRobert Orenstein
The Journal of the American Osteopathic Association|February 28, 2017
History of Osteopathic Medicine: Still Relevant?Robert Orenstein
The Journal of the American Osteopathic Association|August 8, 2007
Study on recurrent otitis media: potential value vs actual value of OMTRobert Orenstein
Nature Reviews. Rheumatology|July 2, 2009
Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?Tim Bongartz, Robert Orenstein
Pharmacotherapy|November 16, 2002
Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infectionRobert Orenstein, Nickolaos Tsogas
Infection and Drug Resistance|May 26, 2023
Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?Sandhya Nagarakanti, Robert Orenstein
Clinical Therapeutics|May 3, 2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusLynn Estes, Robert Orenstein
Journal of Hospital Medicine|March 18, 2010
Disseminated sporotrichosisArif Kamal, Robert Orenstein
Nature Reviews. Rheumatology|October 3, 2012
Immunology: Zoster vaccine and biologic agents: time to question a paradigm?Tim Bongartz, Robert Orenstein
Journal of Investigative Medicine High Impact Case Reports|September 5, 2022
Treatment of Recurrent Vulvovaginal Candidiasis With IbrexafungerpLeah M Grant, Robert Orenstein
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
The Journal of the American Osteopathic Association|October 30, 2014
Emerging infections: the cauldron of medicine, mobility, and mediaRobert Orenstein
The Journal of the American Osteopathic Association|February 28, 2017
History of Osteopathic Medicine: Still Relevant?Robert Orenstein
The Journal of the American Osteopathic Association|August 8, 2007
Study on recurrent otitis media: potential value vs actual value of OMTRobert Orenstein
Nature Reviews. Rheumatology|July 2, 2009
Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?Tim Bongartz, Robert Orenstein
Pharmacotherapy|November 16, 2002
Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infectionRobert Orenstein, Nickolaos Tsogas
Infection and Drug Resistance|May 26, 2023
Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?Sandhya Nagarakanti, Robert Orenstein
Clinical Therapeutics|May 3, 2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusLynn Estes, Robert Orenstein
Journal of Hospital Medicine|March 18, 2010
Disseminated sporotrichosisArif Kamal, Robert Orenstein
Nature Reviews. Rheumatology|October 3, 2012
Immunology: Zoster vaccine and biologic agents: time to question a paradigm?Tim Bongartz, Robert Orenstein
Journal of Investigative Medicine High Impact Case Reports|September 5, 2022
Treatment of Recurrent Vulvovaginal Candidiasis With IbrexafungerpLeah M Grant, Robert Orenstein
Pageof 9